Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Baudax Bio Inc BXRXQ

Healthcare Biotechnology
Baudax Bio, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products for hospital and related acute care settings. The Company's lead product candidate is ANJESO injection. ANJESO is a cyclooxygenase-2 (COX-2), a preferential, non-steroidal anti-inflammatory for the management of moderate to severe pain, which could be administered alone or in... see more

Recent & Breaking News (GREY:BXRXQ)

Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock

GlobeNewswire June 18, 2021

Baudax Bio to Participate in the JMP Securities Life Sciences Conference

GlobeNewswire June 10, 2021

Baudax Bio's ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market

GlobeNewswire June 8, 2021

Baudax Bio Announces $11.9 Million Registered Direct Offering

GlobeNewswire May 31, 2021

Baudax Bio Announces the Cancellation of Adjourned Portion of Annual Shareholder Meeting

GlobeNewswire May 28, 2021

Baudax Bio to Present at the 2021 Jefferies Virtual Healthcare Conference

GlobeNewswire May 27, 2021

Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management

GlobeNewswire May 17, 2021

Leading Independent Advisory Firm Institutional Shareholder Services, Inc. Recommends Baudax Bio Shareholders Vote "For" the Proposed Additional Authorized Shares

GlobeNewswire May 13, 2021

Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote "For" The Additional Authorized Shares

GlobeNewswire May 12, 2021

Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders

GlobeNewswire May 11, 2021

Baudax Bio Reports First Quarter 2021 Financial Results

GlobeNewswire May 5, 2021

Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021

GlobeNewswire April 29, 2021

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine

GlobeNewswire April 26, 2021

Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders

GlobeNewswire April 8, 2021

Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 1, 2021

Baudax Bio to Participate at the Oppenheimer 31st Annual Healthcare Conference

GlobeNewswire March 10, 2021

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer

GlobeNewswire March 8, 2021

Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference

GlobeNewswire March 2, 2021

Baudax Bio Reports 2020 Annual Financial Results

GlobeNewswire February 16, 2021

Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16, 2021

GlobeNewswire February 10, 2021